Patents by Inventor Anna Kabanova

Anna Kabanova has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES AGAINST MULTIDRUG-RESISTANT KLEBSIELLA PNEUMONIAE
    Publication number: 20260226141
    Abstract: The present invention relates to monoclonal antibodies or antigen-binding portion thereof that have a potent antibacterial activity against Klebsiella pneumoniae, in particular against multi-drug resistant Klebsiella pneumoniae strains. The invention relates also to the use of such monoclonal antibodies or antigen-binding portion thereof in therapy, prophylaxis, and diagnosis of Klebsiella pneumoniae infections, in particular Klebsiella pneumoniae dependent diseases.
    Type: Application
    Filed: January 19, 2024
    Publication date: August 6, 2026
    Applicant: FONDAZIONE TOSCANA LIFE SCIENCES
    Inventors: Soraya Bosch, Vittoria Zucconi, Ida Paciello, Emanuele Roscioli, Giampiero Batani, Dario Cardamone, Giuseppe Maccari, Anna Kabanova, Claudia Sala
  • Purification method
    Patent number: 11065323
    Abstract: A process for purifying a Streptococcus pyogenes GAS carbohydrate comprising a step of anionic exchange chromatography. The process provides a good yield of GAS carbohydrate. The saccharides of the invention have low levels of hyaluronic acid, protein and nucleic acid contamination.
    Type: Grant
    Filed: October 27, 2009
    Date of Patent: July 20, 2021
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Paolo Costantino, Francesco Berti, Anna Kabanova, Maria Rosaria Romano
  • Polysaccharide immunogens conjugated to E. coli carrier proteins
    Patent number: 9173954
    Abstract: E. coli proteins have been identified that are useful as carrier proteins to improve a response to a polysaccharide immunogen conjugated to such protein. In particular, AcfD precursor protein (orf3526 polypeptide), Flu antigen 43 protein (orf1364 polypeptide), and Sel1 repeat-containing protein (upec-5211 polypeptide) have been shown to be effective. Additionally, these E. coli proteins can enhance the immune response to glucans, particularly fungal glucans.
    Type: Grant
    Filed: December 30, 2010
    Date of Patent: November 3, 2015
    Assignee: GlaxoSmithKline Biologicals SA
    Inventors: Paolo Costantino, Francesco Berti, Francesca Micoli, Anna Kabanova, Laura Serino, Maria Rosaria Romano, Marta Tontini
  • PURIFICATION METHOD
    Publication number: 20120010398
    Abstract: A process for purifying a Streptococcus pyogenes GAS carbohydrate comprising a step of anionic exchange chromatography. The process provides a good yield of GAS carbohydrate. The saccharides of the invention have low levels of hyaluronic acid, protein and nucleic acid contamination.
    Type: Application
    Filed: October 27, 2009
    Publication date: January 12, 2012
    Applicant: NOVARTIS AG
    Inventors: Paolo Costantino, Francesco Berti, Anna Kabanova, Maria Rosaria Romano